{"ticker": {"uuid": "4b2515d0-abf9-4ff4-b0ab-d6162deca793", "symbol": "KMTS", "name": "Kestra Medical Technologies, Ltd. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Instruments & Supplies"}, "articles": [{"title": "Kestra Medical Technologies (KMTS) Could Be 31% Overvalued As Earnings And 2027 Guidance Land", "summary": "Kestra Medical Technologies (KMTS) shares are under scrutiny after recent earnings, 2027 revenue guidance, and a new term loan facility. Despite a significant 1-year share price increase of 60.4%, the analysis suggests the company might be 31% overvalued, with a fair value estima", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-kmts/kestra-medical-technologies/news/kestra-medical-technologies-kmts-could-be-31-overvalued-as-e", "source_name": "Simply Wall Street", "published_at": "2026-07-16T00:12:13", "published_display": "16 Jul 2026 00:12", "sentiment": "negative", "sentiment_pct": 29, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical (NASDAQ: KMTS) investor Brian Webster plans 15,000-share sale", "summary": "Brian Webster, an investor in Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), has filed a notice for the potential sale of 15,000 common shares valued at $336,609.41. These shares were initially acquired on January 1, 2026, through a restricted share issuance as part of the com", "url": "https://www.stocktitan.net/sec-filings/KMTS/144-kestra-medical-technologies-ltd-sec-filing-3d390e1eee46.html", "source_name": "Stock Titan", "published_at": "2026-07-15T20:12:13", "published_display": "15 Jul 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 8.7% After Earnings Miss", "summary": "Kestra Medical Technologies (NASDAQ:KMTS) saw its stock price fall 8.7% after reporting a quarterly EPS of -$0.67, missing analyst expectations. Despite the earnings miss, the company's revenue reached $28.64 million, and it secured a $200 million non-dilutive term loan facility ", "url": "https://www.marketbeat.com/instant-alerts/kestra-medical-technologies-nasdaqkmts-stock-price-down-87-after-earnings-miss-2026-07-15/", "source_name": "MarketBeat", "published_at": "2026-07-15T14:12:24", "published_display": "15 Jul 2026 14:12", "sentiment": "negative", "sentiment_pct": 37, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Expected to Rise, BTIG Research Analyst Says", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxQbGlTdFBsZTRVV2xKY200c3lhMjRrLUtDZTREd0I2LXhRQWl0aTltRGVkZEZjZ0Y4dmFhVklEWkFyNkJtVl93N0tGY1JSMEhPYXpWMVJJWk9YakdnUmJYV2NKSFdrVDUxMGM0RTNzYm1EcUxhYW92aHRpMDFvLXoxOUFFS3pKR3RTNG9sS0JmY3A5Y1RndHgwYjg4MGg3MXR6Z1ZSWWVnTVhxOThTbWNXaTQ2X2M0U3Q2dllKdUVDQzEweXhveU9oS2c3dGNKQ3FzR1llbC1va1MxOVp0dTU4aXVB?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-15T12:32:39+00:00", "published_display": "15 Jul 2026 12:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies, Ltd. Stock 12\u2011Month Price Target Cut to $27.5, Implies 14% Upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxQTGNGdG11OG55SjIzS1ZDdHRyMlZqSTBMQjJqTjNwYmJHLVpkaU9jcF9hVkEtTzJMeUhIQURKNU5ycEQ5dGJ3cFV4VWs2MlNydDJBT084VlMzc2xRMnpCV09UQU1WaHYxWVZ5TGhCVlpsSkZ2SXJQUUxrdVk2S081RVpMUGs5M2ZJRlVqVGNiOVFSbmt3WE56aGFsV0tid1ZZZmR6aUVtTnFrN3UzVldYN1hfeFcxRzV0RmhuQ0FuN0lGWEZzSG1FdThMcnlmNGhkOElWczRIZlg2bTJJR096anJueG5Ndw?oc=5", "source_name": "TradingView", "published_at": "2026-07-15T10:20:04+00:00", "published_display": "15 Jul 2026 10:20", "sentiment": "negative", "sentiment_pct": 35, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies, Ltd. Stock 12\u2011Month Price Target Raised to $28.43, Implies 18% Upside", "summary": "Kestra Medical Technologies, Ltd. (KMTS) has seen its average 12-month price target increased from $27.71 to $28.43 by 7 analysts, suggesting an 18% potential upside from its July 14th closing price. The analyst consensus remains a \"Buy,\" with 6 analysts recommending Buy and 1 re", "url": "https://www.tradingview.com/news/tradingview:be99371046673:0-kestra-medical-technologies-ltd-stock-12-month-price-target-cut-to-27-5-implies-14-upside/", "source_name": "TradingView", "published_at": "2026-07-15T10:12:24", "published_display": "15 Jul 2026 10:12", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies Ltd (KMTS) Q4 2026 Earnings Call Highlights: Record Revenue Growth ...", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/kestra-medical-technologies-ltd-kmts-050024179.html", "source_name": "GuruFocus.com", "published_at": "2026-07-15T05:00:24+00:00", "published_display": "15 Jul 2026 05:00", "sentiment": "positive", "sentiment_pct": 83, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical (KMTS) Q4 2026 Earnings Call Transcript", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQcmlkUHhlYUJYOU1IMlhpVEl4RWQ4cnNuTlQyRnhoWmUyT0VwZERoVDRiRjBYZC05ZjQ5elRIdktJTHFwaUFiMEx3THFGcFNLWjJ2aUhjcXZNdTRZTERaVEtVNXh0VC1XdDBvNTc4WFFvb19OVGFKckhpTUt5ZHR5Vnl0aVliZVFCTmFTV19QWlZaN1VHb2ptTGpWZHc4VGNSQTR5aENGUTR3R0M3NE4tWA?oc=5", "source_name": "The Motley Fool", "published_at": "2026-07-15T01:09:00+00:00", "published_display": "15 Jul 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies (KMTS) Reports Strong Q4 Fiscal 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNNEVCeEJIZHM4OVhWSmhSMnVfM0FPQ3RsSnVETkZYQXE2T3hWVVliYVpBeTF1YUFMRUh6REdzYzhpSXo5SjRtd3BmeC1iT3ZEVmdHcVYxNGk1cVZVTk9WM0QzeDRUNmllRjJYQkgtNFR4OF94dnFoZWUzV0I5aE1jUzhzQkZObV9KQ0Y2bTA2RHZiSG1CWnhFam82d2tXLVlnQlQ0M1JOX3dpQ3ZrZjZj?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-15T00:02:42+00:00", "published_display": "15 Jul 2026 00:02", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies Q4 Earnings Call Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPOEVqX2F4ZE5PeTY0YWpIZFdJYXFQVUJQbXgxbU5nWUFxM0g5M3NyajFYblV6YnRlRTUwRlFraE45QXRsQXA0M0dLdXNTdVFmM1NmTXZETUdEdDRRWENxOVhVYWtRZlM0NGxCYl8yNU1OeVZOXzk1UmFCVmlKdEQ5dm5oNE5VNS1XZXIwNUpCcHVVZXRjbDNncld0ZFpfTzctWU5kWUhSdGo4S1JDT3c?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-14T22:04:56+00:00", "published_display": "14 Jul 2026 22:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical (NASDAQ: KMTS) targets $24B wearable defibrillator market", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOMk01eko1MzlGNzhLNzB3ZkRIS2N4V2FaRVZqZlZGWnpNTjJMMGJVcGRqWk9saGZpNEpYaVZrR3RkeW02NVRUWVE0RDVqb3hRWnM4NEd6OUJuRVltcG05UmhDVkp3ZU9aaUhhOGhKVVJ3R0xFallHTmdPNlp3b3l5T3BpQmc5bWRHWVF6YkdkMlBVS1FMSUduZ2lHUG0xeG5adUpXX3d6WlVpM3VPLXBHVThqM3AyM0lScmc?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T21:25:48+00:00", "published_display": "14 Jul 2026 21:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "KESTRA MEDICAL TECHNOLOGIES ($KMTS) Releases Q4 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNeWI3YzA0a19VemlwekxfYnltQXVvNHdxbGdlaTh4bWhqSWxNV2hVYXh2VG1lWEkyUVpwMDFkeVBwZXNTUWsza0QxTlpuYU1LSG9sU1gweWtVN3dpWlJJZUQ0STBuYWlSdnlpazlVdFhqZHdaV1VaWklZMW1GTFE0SUNkZXIwdWh3a2N2VUZfNFVZNEFzNVk1a0hvdFA1WG0tZ1E?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-14T20:30:00+00:00", "published_display": "14 Jul 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "KESTRA MEDICAL TECHNOLOGIES, LTD. FY 2026: Revenue $95.1M, Net income $(131.6M) \u2014 10-K Summary", "summary": "Kestra Medical Technologies, Ltd. (KMTS) reported fiscal year 2026 revenue of $95.1 million, a 59% increase year-over-year, alongside a net loss of $(131.6) million, which widened from the previous year. The revenue growth was primarily driven by a 58% increase in patient volume ", "url": "https://www.tradingview.com/news/tradingview:fbf89aabe8df3:0-kestra-medical-technologies-ltd-fy-2026-revenue-95-1m-net-income-131-6m-10-k-summary/", "source_name": "TradingView", "published_at": "2026-07-14T21:13:46", "published_display": "14 Jul 2026 21:13", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimates", "summary": "Kestra Medical Technologies, Ltd. (KMTS) reported a Q4 loss of $0.67 per share, which was worse than the Zacks Consensus Estimate of a $0.59 loss, marking a -13.56% surprise. However, the company surpassed revenue estimates, posting $28.64 million, exceeding the consensus by 8.05", "url": "https://sg.finance.yahoo.com/news/kestra-medical-technologies-ltd-kmts-211002386.html", "source_name": "Market source", "published_at": "2026-07-14T21:10:00", "published_display": "14 Jul 2026 21:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Flash (KMTS) Kestra Medical Technologies Posts Fiscal Q4 Per-Share Loss $0.67, vs. FactSet Est of Loss $0.59", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxNaUlaWmNkOVNmNXdWMEF6cWhMd25HQ1VRb3haaUsycmlJR3MtUE9xNUJnVUtwb3Zsa0RLdFJCb2ZweGtjNW5YV3psbmE3S0lRV2RsNm9EZmJXRzFVa1JXM1JNRUM0NHZiUlhxdl96dC0tdHd4cmNvVTlvR2JfeU9qeWRVMFNCeldzNHozRHJ4RHUxb25ocFdXSjBocW0xcDRMWEJOMjF5UkZCOUo3RDBWLTBNbGY4WnJSeU5zZGZEUDZFVW5NYWhCMDMybG1fcHVYVzdMaWIzS3diSVNSeHRuTA?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-14T20:06:21+00:00", "published_display": "14 Jul 2026 20:06", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra's up-to-$200M facility includes $50M for acquisitions", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPcUpYWmFyVUltcmhncGNTYkZndVlrVlkxbk1wYUtVc2RyMExaTGpCb0oyVGNmY2RpMnl0UkZ6WWZlY0VXbGxWWWFKZHRnMGZvYkxjNGczNUE5b0dIY09IUU5iR1BsX1d2dEJPU1huYldMWFF4bndGV1VCZ0V0SzFDTlhnV25odDNIVHpFN1pGVllFM0llNE9SbmtfYmFEQzU4eEdZRHU1WDk3N2hGVUgzWmtvcDVMUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T20:05:00+00:00", "published_display": "14 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra says ASSURE system protected 18,000 patients in FY26", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQWmlsczRhTGtWRmtwNzMxRVhISlFwdnpUTFk0NzZUdlN1Z0tPYlFsdjF5VTlzZm1Pc1lhOGZ1RWpjdV9nTWpFQlh4R190QVFlUXl4RzZ2MmdfS1dkQ29DYlZJWmVvVkhGRXk5b1llZk5MZUFwaU52Q1FTNFJjMEFScGxkU2ZadFNLcWRhdG1hWXJ4S2Itd1l4ZUs2MjNRS2J1OEJUak5rcy04NkJrQTdwY0VjRUlLNkw3cEpqVmVR?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T20:01:00+00:00", "published_display": "14 Jul 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results", "summary": "Kestra Medical Technologies (Nasdaq: KMTS) reported strong financial results for the fourth quarter and fiscal year ended April 30, 2026, with revenue increasing by 66% and 59% respectively, and significant gross margin expansion. The company's ASSURE\u00ae system protected 18,000 pat", "url": "https://www.globenewswire.com/news-release/2026/07/14/3327235/0/en/kestra-medical-technologies-reports-fourth-quarter-and-fiscal-year-2026-financial-results.html", "source_name": "GlobeNewswire", "published_at": "2026-07-14T20:13:46", "published_display": "14 Jul 2026 20:13", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical (Nasdaq: KMTS) adds $200M loan as revenue surges 59%", "summary": "Kestra Medical Technologies (KMTS) secured a five-year senior secured term loan facility of up to $200 million with Pharmakon Advisors, with the initial Tranche A of $75 million funding on July 10, 2026. The company reported significant revenue growth for fiscal year 2026, reachi", "url": "https://www.stocktitan.net/sec-filings/KMTS/8-k-kestra-medical-technologies-ltd-reports-material-event-6d7dbb9e0621.html", "source_name": "Stock Titan", "published_at": "2026-07-14T20:13:46", "published_display": "14 Jul 2026 20:13", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing", "summary": "Kestra Medical Technologies has secured up to $200 million in non-dilutive financing through a five-year term loan facility with Pharmakon Advisors, LP. This financing strengthens Kestra's balance sheet, reduces its cost of capital, and provides significant flexibility to invest ", "url": "https://www.manilatimes.net/2026/07/15/tmt-newswire/globenewswire/kestra-medical-technologies-secures-up-to-200-million-of-non-dilutive-financing/2384543", "source_name": "The Manila Times", "published_at": "2026-07-14T20:13:46", "published_display": "14 Jul 2026 20:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical secures $75M loan facility with Pharmakon", "summary": "Kestra Medical Technologies has secured a five-year term loan facility of up to $200 million with funds managed by Pharmakon Advisors, LP. This financing includes an initial $75 million tranche, with additional tranches available based on revenue milestones or for acquisitions. T", "url": "https://www.investing.com/news/company-news/kestra-medical-secures-75m-loan-facility-with-pharmakon-93CH-4791614", "source_name": "Investing.com", "published_at": "2026-07-14T20:13:46", "published_display": "14 Jul 2026 20:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Press Release: Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing", "summary": "Kestra Medical Technologies has secured up to $200 million in non-dilutive financing from a fund managed by leading global investment firm Carlyle. This significant funding will support Kestra's growth, expand its commercial efforts for the Assure\u00ae Wearable Cardioverter Defibrill", "url": "https://www.moomoo.com/th/news/post/72957133/press-release-kestra-medical-technologies-secures-up-to-200-million?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-14T20:12:24", "published_display": "14 Jul 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings To Watch: Kestra Medical Technologies Ltd (KMTS) Reports Q4 2026 Result", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOX2RGS2YzU0F5Sm1KOTFZTm1lOTBMbjhITTdQb3hiU2VLeFVtSndmbkp3amdvd3BaeWhwSU1BUDN6QUJZR01UcjdMazU5NFZrVklTNUxIME1wcUlZTk5EWG9yTTRhRVhtRWswSnZnWFI0WHM2MksxbkMtUVZuZHVZbGV1M1JyZTZtUHVXVjdPMzM0TFVoLUZrRG5uUVROZS1Wd21NdUZpaExzWkU?oc=5", "source_name": "Market source", "published_at": "2026-07-13T13:17:35+00:00", "published_display": "13 Jul 2026 13:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Kestra Medical Technologies Ltd. Stocks", "summary": "This article lists various ETFs that currently hold stocks of Kestra Medical Technologies Ltd. (KMTS). It provides a table detailing each ETF's market value, weight, issuer, management style, focus, expense ratio, AUM, price change percentage, relative volume, and 3-year NAV tota", "url": "https://www.tradingview.com/symbols/NASDAQ-KMTS/etfs/", "source_name": "TradingView", "published_at": "2026-07-08T20:41:51", "published_display": "08 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "KMTS Q4'25 Earnings: revenue estimate is 26.48M USD", "summary": "Kestra Medical Technologies, Ltd. (KMTS) is scheduled to release its Q4'25 earnings on July 14, before market open. The company anticipates revenues of $26.48 million USD and an EPS of -$0.59 for the quarter. This article provides a detailed look at past revenue and EPS figures, ", "url": "https://www.tradingview.com/news/tradingview:b08e58af1c8a5:0-kmts-q4-25-earnings-revenue-estimate-is-26-48m-usd/", "source_name": "TradingView", "published_at": "2026-07-07T11:10:19", "published_display": "07 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "KMTS - Kestra Medical Technologies Ltd Options", "summary": "This article provides a detailed financial overview of Kestra Medical Technologies Ltd (KMTS), including its stock performance, market capitalization, income, sales, and various financial ratios. It also lists insider and institutional ownership, analyst recommendations, and othe", "url": "https://finviz.com/stock?t=KMTS&ta=1&p=d&ty=oc&b=1&r=m6", "source_name": "Finviz", "published_at": "2026-07-03T16:10:14", "published_display": "03 Jul 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical (KMTS) CBO adds 227 ESPP shares, now holds 42,488", "summary": "Kestra Medical Technologies' Chief Business Officer, Timothy P. Moran, purchased 227 shares of common stock through the company's 2025 Employee Stock Purchase Plan (ESPP) on June 30, 2026, at a price of $21.55 per share. This transaction, which was exempt under Rule 16b-3, increa", "url": "https://www.stocktitan.net/sec-filings/KMTS/form-4-kestra-medical-technologies-ltd-insider-trading-activity-5ceeaeb7d708.html", "source_name": "Stock Titan", "published_at": "2026-07-02T21:09:38", "published_display": "02 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical (KMTS) director and officer acquires 942 ESPP shares", "summary": "Kestra Medical Technologies director and officer Traci S. Umberger acquired 942 shares of common stock through the company's Employee Stock Purchase Plan at $21.55 per share. This purchase, exempt under Rule 16b-3, brings Umberger's beneficial ownership to 162,802 shares, includi", "url": "https://www.stocktitan.net/sec-filings/KMTS/form-4-kestra-medical-technologies-ltd-insider-trading-activity-81bd31ae21fc.html", "source_name": "Stock Titan", "published_at": "2026-07-02T21:09:38", "published_display": "02 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies to report Q4FY26 results on July 14", "summary": "Kestra Medical Technologies, a wearable medical device and digital healthcare company, will announce its Q4FY26 financial results after the market closes on July 14. This will be followed by a conference call at 4:30 p.m. ET to discuss the results and performance metrics for the ", "url": "https://scanx.trade/stock-market-news/companies/kestra-medical-technologies-to-report-q4fy26-results-on-july-14/44405856", "source_name": "scanx.trade", "published_at": "2026-07-01T04:27:00", "published_display": "01 Jul 2026 04:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies to Report Fourth Quarter Fiscal 2026 Financial Results on July 14", "summary": "Kestra Medical Technologies (Nasdaq: KMTS) announced it will report its fourth-quarter fiscal 2026 financial results after market close on Tuesday, July 14. The company will also host a conference call at 4:30 p.m. Eastern Time to discuss the results. A webcast of the call will b", "url": "https://finance.yahoo.com/healthcare/articles/kestra-medical-technologies-report-fourth-200500345.html", "source_name": "Market source", "published_at": "2026-07-01T02:39:48", "published_display": "01 Jul 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical sets July 14 earnings call after market close", "summary": "Kestra Medical Technologies (Nasdaq: KMTS) is scheduled to report its fourth-quarter fiscal 2026 financial results on Tuesday, July 14, after the market closes. Following the release, management will host a conference call at 4:30 p.m. Eastern Time to discuss the results, with a ", "url": "https://www.stocktitan.net/news/KMTS/kestra-medical-technologies-to-report-fourth-quarter-fiscal-2026-rntx9qpe8ahg.html", "source_name": "Stock Titan", "published_at": "2026-06-30T20:09:57", "published_display": "30 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies, Ltd.(NasdaqGS:KMTS) dropped from Russell 2000 Value Benchmark", "summary": "Kestra Medical Technologies, Ltd. (NasdaqGS:KMTS) has been dropped from the Russell 2000 Value Benchmark. This news follows several other announcements about the company being removed from various Russell indices around the same date in June 2026. The company is a commercial-stag", "url": "https://www.marketscreener.com/news/kestra-medical-technologies-ltd-nasdaqgs-kmts-dropped-from-russell-2000-value-benchmark-ce7f5fdcd888ff25", "source_name": "marketscreener.com", "published_at": "2026-06-30T07:10:05", "published_display": "30 Jun 2026 07:10", "sentiment": "negative", "sentiment_pct": 33, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies, Ltd.(NasdaqGS:KMTS) dropped from Russell 2500 Value Benchmark", "summary": "Kestra Medical Technologies, Ltd. (NasdaqGS: KMTS) has been removed from the Russell 2500 Value Benchmark. The company's stock shows a 3.34% increase today and a 5.13% year-to-date change. Kestra Medical Technologies specializes in wearable medical devices for cardiovascular dise", "url": "https://www.marketscreener.com/news/kestra-medical-technologies-ltd-nasdaqgs-kmts-dropped-from-russell-2500-value-benchmark-ce7f5fded880ff23", "source_name": "marketscreener.com", "published_at": "2026-06-30T04:40:32", "published_display": "30 Jun 2026 04:40", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies, Ltd.(NasdaqGS:KMTS) dropped from Russell 3000 Value Benchmark", "summary": "Kestra Medical Technologies, Ltd. (NasdaqGS:KMTS) has been removed from the Russell 3000 Value Benchmark. This news follows several other recent announcements where the company was dropped from various Russell indices, including the Russell Small Cap Comp Value and Russell 2500 V", "url": "https://www.marketscreener.com/news/kestra-medical-technologies-ltd-nasdaqgs-kmts-dropped-from-russell-3000-value-benchmark-ce7f5fdeda8ff622", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T14:39:15", "published_display": "29 Jun 2026 14:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies, Ltd.(NasdaqGS:KMTS) dropped from Russell Small Cap Comp Value Benchmark", "summary": "Kestra Medical Technologies, Ltd. (NasdaqGS:KMTS) has been removed from the Russell Small Cap Comp Value Benchmark. The company's stock experienced a slight drop of 0.79% on the day this news was published. This follows previous removals from other Russell indices and comes amids", "url": "https://www.marketscreener.com/news/kestra-medical-technologies-ltd-nasdaqgs-kmts-dropped-from-russell-small-cap-comp-value-benchmark-ce7f5fdede8df224", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T10:42:37", "published_display": "29 Jun 2026 10:42", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Kestra Medical Technologies (KMTS) Fully Priced As Sales Expansion Fuels The Bull Case?", "summary": "Kestra Medical Technologies (KMTS) has seen significant stock movement recently, prompting a closer look at its valuation. While a bullish narrative suggests it is 11.9% undervalued with a fair value of $30.00 due to sales force expansion and revenue growth, the company's current", "url": "https://www.sahmcapital.com/news/content/is-kestra-medical-technologies-kmts-fully-priced-as-sales-expansion-fuels-the-bull-case-2026-06-27", "source_name": "Sahm", "published_at": "2026-06-28T02:09:57", "published_display": "28 Jun 2026 02:09", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "KESTRA MEDICAL TECHNOLOGIES ($KMTS) Releases Q3 2026 Earnings, Stock Rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNdi0wOTYyRGJTX25WM3FJSU9KR0xJVDctLXV0aDhHLTVNNnJNWWxrNjhmU2xMMWFkTVRNUkFNc29CS280Q3VFeEtEZjZ4ZlYwZ2pCTzhVNGpQUEF3OXVUc1BaaWZwWW4xb1dLd3Q3SjBrZXBWN21FR2hKQm5OR3hHTElpZFFQM0l6UDdTMW00bDBLZkpOOHVfeDQxNVVzOFlfcV9aSnFQWktoNkU?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-27T06:26:29+00:00", "published_display": "27 Jun 2026 06:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies Ltd. Actuals & Estimates (NASDAQ:KMTS)", "summary": "This article provides financial actuals and estimates for Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), including its current stock price, market capitalization, and analyst forecasts. It details the company's past performance, upcoming earnings report, and financial metrics l", "url": "https://www.tradingview.com/symbols/NASDAQ-KMTS/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T01:09:11", "published_display": "27 Jun 2026 01:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "KMTS Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "The article provides a price target and forecast for Kestra Medical Technologies, Ltd. (KMTS) stock, based on analyst opinions. It includes current stock performance metrics, historical price data, financial statements, and answers frequently asked questions about the company's s", "url": "https://www.tradingview.com/symbols/NASDAQ-KMTS/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T14:09:40", "published_display": "25 Jun 2026 14:09", "sentiment": "positive", "sentiment_pct": 65, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQODBOU3plc3JYZ2VxcEZ6UFo5VzV1V3lQZ2dqZjVlWTlIZjRlUFlKLV8zYU0tQUlxcUtqNkRGS3dYTlBIWEw5ZWY2d05iRDBmbG80d3dQb1BseXRZUHBPTlZuOTFVQkhETGI0Vmk5OWpkcF9rYkdvbmxVM3pEcjhwU3BtMzFqX3YtQm9tVl9BSjhmMk80eU14S090M1AtR0hGSHc?oc=5", "source_name": "The Motley Fool", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies to Present at the BofA Securities 2026 Healthcare Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/kestra-medical-technologies-present-bofa-100000458.html", "source_name": "GlobeNewswire", "published_at": "2026-04-29T10:00:00+00:00", "published_display": "29 Apr 2026 10:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Showcases Accelerated Innovation at HRS 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/kestra-showcases-accelerated-innovation-hrs-120000033.html", "source_name": "GlobeNewswire", "published_at": "2026-04-22T12:00:00+00:00", "published_display": "22 Apr 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNd284TGpzWVFzSThkSlNjUE8zZjVWTGE0UnVGYW9kWk91ckhyMkhoUFZzMzBZWThjZWJ6SlJCM284bWRvUWtuZUZkX0dLTnlDRjVNWU5ONWtfdE1pR3Q5NzNDNFRTcGVhcVNVS2lzMG5KRXVGOXVLYXIzSWNwbXo0RUxTUnpwVlFTV0lrall3Z2Nzd2tiMlNRSFJMMG5yWG9kUS1kXzFZZ0lieDg?oc=5", "source_name": "Market source", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Kestra Medical Technologies (KMTS) Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNT0EyamNEZ1gwQjdKQmdEa2txVFRObVVPZWMzWU9sY3hEWm1rMGt5WjhSLW05aUVuaC1tSV9YX2NPaFVLTWZ6VVpEUmd4cGRBNnIybnlKckJQUVgyVmJ0Q1dVZVJydXl4OUJZdl9GRFpTSmVwYmp2dUxxUVhwaDVDaWpxRDFCOE9TenZValFYODNPY3FjSkpGUF9jdVkwdEhIb3RzNVB6aExBMzQ?oc=5", "source_name": "Market source", "published_at": "2026-03-28T07:00:00+00:00", "published_display": "28 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies (KMTS) Revenue Growth Versus Ongoing EPS Losses Tests Bullish Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn\u2019t the Only Problem.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMTdzUkZQWG9tTW9zT3FxSWtzdkdLLUNYVkRJMDh2X1VRSlVrdmVkS3FCSVFpX210VUxVSUF1Q2FYakw1ZUxyQlpoZHZpM1RYQzBOYlpEWENxeGM1bXBZNFYxQjZRcFBpcS0tVVhRdzFTejBrVzU3aU9QQXdnYkZBMWxB?oc=5", "source_name": "Barron's", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Kestra Medical Technologies (NASDAQ:KMTS) A Risky Investment?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-09T07:00:00+00:00", "published_display": "09 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "KESTRA MED TECHNOLOGIES (KMTS) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFAyM0pSX3FHZzMzSGJuRmRvM3RyUWhpazQtSS01LUIzbjZLbWFzX1h3MEY4Ymk3d3k5U1IzUkZyeEtzNUVfblpXSG1MaUtZcHB1VXM0?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T17:15:22+00:00", "published_display": "24 Apr 2025 17:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Kestra Medical Technologies (KMTS) Could Be 31% Overvalued As Earnings And 2027 Guidance Land", "summary": "Kestra Medical Technologies (KMTS) shares are under scrutiny after recent earnings, 2027 revenue guidance, and a new term loan facility. Despite a significant 1-year share price increase of 60.4%, the analysis suggests the company might be 31% overvalued, with a fair value estima", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-kmts/kestra-medical-technologies/news/kestra-medical-technologies-kmts-could-be-31-overvalued-as-e", "source_name": "Simply Wall Street", "published_at": "2026-07-16T00:12:13", "published_display": "16 Jul 2026 00:12", "sentiment": "negative", "sentiment_pct": 29, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical (NASDAQ: KMTS) investor Brian Webster plans 15,000-share sale", "summary": "Brian Webster, an investor in Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), has filed a notice for the potential sale of 15,000 common shares valued at $336,609.41. These shares were initially acquired on January 1, 2026, through a restricted share issuance as part of the com", "url": "https://www.stocktitan.net/sec-filings/KMTS/144-kestra-medical-technologies-ltd-sec-filing-3d390e1eee46.html", "source_name": "Stock Titan", "published_at": "2026-07-15T20:12:13", "published_display": "15 Jul 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 8.7% After Earnings Miss", "summary": "Kestra Medical Technologies (NASDAQ:KMTS) saw its stock price fall 8.7% after reporting a quarterly EPS of -$0.67, missing analyst expectations. Despite the earnings miss, the company's revenue reached $28.64 million, and it secured a $200 million non-dilutive term loan facility ", "url": "https://www.marketbeat.com/instant-alerts/kestra-medical-technologies-nasdaqkmts-stock-price-down-87-after-earnings-miss-2026-07-15/", "source_name": "MarketBeat", "published_at": "2026-07-15T14:12:24", "published_display": "15 Jul 2026 14:12", "sentiment": "negative", "sentiment_pct": 37, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Expected to Rise, BTIG Research Analyst Says", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxQbGlTdFBsZTRVV2xKY200c3lhMjRrLUtDZTREd0I2LXhRQWl0aTltRGVkZEZjZ0Y4dmFhVklEWkFyNkJtVl93N0tGY1JSMEhPYXpWMVJJWk9YakdnUmJYV2NKSFdrVDUxMGM0RTNzYm1EcUxhYW92aHRpMDFvLXoxOUFFS3pKR3RTNG9sS0JmY3A5Y1RndHgwYjg4MGg3MXR6Z1ZSWWVnTVhxOThTbWNXaTQ2X2M0U3Q2dllKdUVDQzEweXhveU9oS2c3dGNKQ3FzR1llbC1va1MxOVp0dTU4aXVB?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-15T12:32:39+00:00", "published_display": "15 Jul 2026 12:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies, Ltd. Stock 12\u2011Month Price Target Cut to $27.5, Implies 14% Upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxQTGNGdG11OG55SjIzS1ZDdHRyMlZqSTBMQjJqTjNwYmJHLVpkaU9jcF9hVkEtTzJMeUhIQURKNU5ycEQ5dGJ3cFV4VWs2MlNydDJBT084VlMzc2xRMnpCV09UQU1WaHYxWVZ5TGhCVlpsSkZ2SXJQUUxrdVk2S081RVpMUGs5M2ZJRlVqVGNiOVFSbmt3WE56aGFsV0tid1ZZZmR6aUVtTnFrN3UzVldYN1hfeFcxRzV0RmhuQ0FuN0lGWEZzSG1FdThMcnlmNGhkOElWczRIZlg2bTJJR096anJueG5Ndw?oc=5", "source_name": "TradingView", "published_at": "2026-07-15T10:20:04+00:00", "published_display": "15 Jul 2026 10:20", "sentiment": "negative", "sentiment_pct": 35, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies, Ltd. Stock 12\u2011Month Price Target Raised to $28.43, Implies 18% Upside", "summary": "Kestra Medical Technologies, Ltd. (KMTS) has seen its average 12-month price target increased from $27.71 to $28.43 by 7 analysts, suggesting an 18% potential upside from its July 14th closing price. The analyst consensus remains a \"Buy,\" with 6 analysts recommending Buy and 1 re", "url": "https://www.tradingview.com/news/tradingview:be99371046673:0-kestra-medical-technologies-ltd-stock-12-month-price-target-cut-to-27-5-implies-14-upside/", "source_name": "TradingView", "published_at": "2026-07-15T10:12:24", "published_display": "15 Jul 2026 10:12", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies Ltd (KMTS) Q4 2026 Earnings Call Highlights: Record Revenue Growth ...", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/kestra-medical-technologies-ltd-kmts-050024179.html", "source_name": "GuruFocus.com", "published_at": "2026-07-15T05:00:24+00:00", "published_display": "15 Jul 2026 05:00", "sentiment": "positive", "sentiment_pct": 83, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical (KMTS) Q4 2026 Earnings Call Transcript", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQcmlkUHhlYUJYOU1IMlhpVEl4RWQ4cnNuTlQyRnhoWmUyT0VwZERoVDRiRjBYZC05ZjQ5elRIdktJTHFwaUFiMEx3THFGcFNLWjJ2aUhjcXZNdTRZTERaVEtVNXh0VC1XdDBvNTc4WFFvb19OVGFKckhpTUt5ZHR5Vnl0aVliZVFCTmFTV19QWlZaN1VHb2ptTGpWZHc4VGNSQTR5aENGUTR3R0M3NE4tWA?oc=5", "source_name": "The Motley Fool", "published_at": "2026-07-15T01:09:00+00:00", "published_display": "15 Jul 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies (KMTS) Reports Strong Q4 Fiscal 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNNEVCeEJIZHM4OVhWSmhSMnVfM0FPQ3RsSnVETkZYQXE2T3hWVVliYVpBeTF1YUFMRUh6REdzYzhpSXo5SjRtd3BmeC1iT3ZEVmdHcVYxNGk1cVZVTk9WM0QzeDRUNmllRjJYQkgtNFR4OF94dnFoZWUzV0I5aE1jUzhzQkZObV9KQ0Y2bTA2RHZiSG1CWnhFam82d2tXLVlnQlQ0M1JOX3dpQ3ZrZjZj?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-15T00:02:42+00:00", "published_display": "15 Jul 2026 00:02", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies Q4 Earnings Call Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPOEVqX2F4ZE5PeTY0YWpIZFdJYXFQVUJQbXgxbU5nWUFxM0g5M3NyajFYblV6YnRlRTUwRlFraE45QXRsQXA0M0dLdXNTdVFmM1NmTXZETUdEdDRRWENxOVhVYWtRZlM0NGxCYl8yNU1OeVZOXzk1UmFCVmlKdEQ5dm5oNE5VNS1XZXIwNUpCcHVVZXRjbDNncld0ZFpfTzctWU5kWUhSdGo4S1JDT3c?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-14T22:04:56+00:00", "published_display": "14 Jul 2026 22:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical (NASDAQ: KMTS) targets $24B wearable defibrillator market", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOMk01eko1MzlGNzhLNzB3ZkRIS2N4V2FaRVZqZlZGWnpNTjJMMGJVcGRqWk9saGZpNEpYaVZrR3RkeW02NVRUWVE0RDVqb3hRWnM4NEd6OUJuRVltcG05UmhDVkp3ZU9aaUhhOGhKVVJ3R0xFallHTmdPNlp3b3l5T3BpQmc5bWRHWVF6YkdkMlBVS1FMSUduZ2lHUG0xeG5adUpXX3d6WlVpM3VPLXBHVThqM3AyM0lScmc?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T21:25:48+00:00", "published_display": "14 Jul 2026 21:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "KESTRA MEDICAL TECHNOLOGIES ($KMTS) Releases Q4 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNeWI3YzA0a19VemlwekxfYnltQXVvNHdxbGdlaTh4bWhqSWxNV2hVYXh2VG1lWEkyUVpwMDFkeVBwZXNTUWsza0QxTlpuYU1LSG9sU1gweWtVN3dpWlJJZUQ0STBuYWlSdnlpazlVdFhqZHdaV1VaWklZMW1GTFE0SUNkZXIwdWh3a2N2VUZfNFVZNEFzNVk1a0hvdFA1WG0tZ1E?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-14T20:30:00+00:00", "published_display": "14 Jul 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "KESTRA MEDICAL TECHNOLOGIES, LTD. FY 2026: Revenue $95.1M, Net income $(131.6M) \u2014 10-K Summary", "summary": "Kestra Medical Technologies, Ltd. (KMTS) reported fiscal year 2026 revenue of $95.1 million, a 59% increase year-over-year, alongside a net loss of $(131.6) million, which widened from the previous year. The revenue growth was primarily driven by a 58% increase in patient volume ", "url": "https://www.tradingview.com/news/tradingview:fbf89aabe8df3:0-kestra-medical-technologies-ltd-fy-2026-revenue-95-1m-net-income-131-6m-10-k-summary/", "source_name": "TradingView", "published_at": "2026-07-14T21:13:46", "published_display": "14 Jul 2026 21:13", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimates", "summary": "Kestra Medical Technologies, Ltd. (KMTS) reported a Q4 loss of $0.67 per share, which was worse than the Zacks Consensus Estimate of a $0.59 loss, marking a -13.56% surprise. However, the company surpassed revenue estimates, posting $28.64 million, exceeding the consensus by 8.05", "url": "https://sg.finance.yahoo.com/news/kestra-medical-technologies-ltd-kmts-211002386.html", "source_name": "Market source", "published_at": "2026-07-14T21:10:00", "published_display": "14 Jul 2026 21:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Flash (KMTS) Kestra Medical Technologies Posts Fiscal Q4 Per-Share Loss $0.67, vs. FactSet Est of Loss $0.59", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxNaUlaWmNkOVNmNXdWMEF6cWhMd25HQ1VRb3haaUsycmlJR3MtUE9xNUJnVUtwb3Zsa0RLdFJCb2ZweGtjNW5YV3psbmE3S0lRV2RsNm9EZmJXRzFVa1JXM1JNRUM0NHZiUlhxdl96dC0tdHd4cmNvVTlvR2JfeU9qeWRVMFNCeldzNHozRHJ4RHUxb25ocFdXSjBocW0xcDRMWEJOMjF5UkZCOUo3RDBWLTBNbGY4WnJSeU5zZGZEUDZFVW5NYWhCMDMybG1fcHVYVzdMaWIzS3diSVNSeHRuTA?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-14T20:06:21+00:00", "published_display": "14 Jul 2026 20:06", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra's up-to-$200M facility includes $50M for acquisitions", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPcUpYWmFyVUltcmhncGNTYkZndVlrVlkxbk1wYUtVc2RyMExaTGpCb0oyVGNmY2RpMnl0UkZ6WWZlY0VXbGxWWWFKZHRnMGZvYkxjNGczNUE5b0dIY09IUU5iR1BsX1d2dEJPU1huYldMWFF4bndGV1VCZ0V0SzFDTlhnV25odDNIVHpFN1pGVllFM0llNE9SbmtfYmFEQzU4eEdZRHU1WDk3N2hGVUgzWmtvcDVMUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T20:05:00+00:00", "published_display": "14 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra says ASSURE system protected 18,000 patients in FY26", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQWmlsczRhTGtWRmtwNzMxRVhISlFwdnpUTFk0NzZUdlN1Z0tPYlFsdjF5VTlzZm1Pc1lhOGZ1RWpjdV9nTWpFQlh4R190QVFlUXl4RzZ2MmdfS1dkQ29DYlZJWmVvVkhGRXk5b1llZk5MZUFwaU52Q1FTNFJjMEFScGxkU2ZadFNLcWRhdG1hWXJ4S2Itd1l4ZUs2MjNRS2J1OEJUak5rcy04NkJrQTdwY0VjRUlLNkw3cEpqVmVR?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T20:01:00+00:00", "published_display": "14 Jul 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results", "summary": "Kestra Medical Technologies (Nasdaq: KMTS) reported strong financial results for the fourth quarter and fiscal year ended April 30, 2026, with revenue increasing by 66% and 59% respectively, and significant gross margin expansion. The company's ASSURE\u00ae system protected 18,000 pat", "url": "https://www.globenewswire.com/news-release/2026/07/14/3327235/0/en/kestra-medical-technologies-reports-fourth-quarter-and-fiscal-year-2026-financial-results.html", "source_name": "GlobeNewswire", "published_at": "2026-07-14T20:13:46", "published_display": "14 Jul 2026 20:13", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical (Nasdaq: KMTS) adds $200M loan as revenue surges 59%", "summary": "Kestra Medical Technologies (KMTS) secured a five-year senior secured term loan facility of up to $200 million with Pharmakon Advisors, with the initial Tranche A of $75 million funding on July 10, 2026. The company reported significant revenue growth for fiscal year 2026, reachi", "url": "https://www.stocktitan.net/sec-filings/KMTS/8-k-kestra-medical-technologies-ltd-reports-material-event-6d7dbb9e0621.html", "source_name": "Stock Titan", "published_at": "2026-07-14T20:13:46", "published_display": "14 Jul 2026 20:13", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing", "summary": "Kestra Medical Technologies has secured up to $200 million in non-dilutive financing through a five-year term loan facility with Pharmakon Advisors, LP. This financing strengthens Kestra's balance sheet, reduces its cost of capital, and provides significant flexibility to invest ", "url": "https://www.manilatimes.net/2026/07/15/tmt-newswire/globenewswire/kestra-medical-technologies-secures-up-to-200-million-of-non-dilutive-financing/2384543", "source_name": "The Manila Times", "published_at": "2026-07-14T20:13:46", "published_display": "14 Jul 2026 20:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical secures $75M loan facility with Pharmakon", "summary": "Kestra Medical Technologies has secured a five-year term loan facility of up to $200 million with funds managed by Pharmakon Advisors, LP. This financing includes an initial $75 million tranche, with additional tranches available based on revenue milestones or for acquisitions. T", "url": "https://www.investing.com/news/company-news/kestra-medical-secures-75m-loan-facility-with-pharmakon-93CH-4791614", "source_name": "Investing.com", "published_at": "2026-07-14T20:13:46", "published_display": "14 Jul 2026 20:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Press Release: Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing", "summary": "Kestra Medical Technologies has secured up to $200 million in non-dilutive financing from a fund managed by leading global investment firm Carlyle. This significant funding will support Kestra's growth, expand its commercial efforts for the Assure\u00ae Wearable Cardioverter Defibrill", "url": "https://www.moomoo.com/th/news/post/72957133/press-release-kestra-medical-technologies-secures-up-to-200-million?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-14T20:12:24", "published_display": "14 Jul 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings To Watch: Kestra Medical Technologies Ltd (KMTS) Reports Q4 2026 Result", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOX2RGS2YzU0F5Sm1KOTFZTm1lOTBMbjhITTdQb3hiU2VLeFVtSndmbkp3amdvd3BaeWhwSU1BUDN6QUJZR01UcjdMazU5NFZrVklTNUxIME1wcUlZTk5EWG9yTTRhRVhtRWswSnZnWFI0WHM2MksxbkMtUVZuZHVZbGV1M1JyZTZtUHVXVjdPMzM0TFVoLUZrRG5uUVROZS1Wd21NdUZpaExzWkU?oc=5", "source_name": "Market source", "published_at": "2026-07-13T13:17:35+00:00", "published_display": "13 Jul 2026 13:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Kestra Medical Technologies Ltd. Stocks", "summary": "This article lists various ETFs that currently hold stocks of Kestra Medical Technologies Ltd. (KMTS). It provides a table detailing each ETF's market value, weight, issuer, management style, focus, expense ratio, AUM, price change percentage, relative volume, and 3-year NAV tota", "url": "https://www.tradingview.com/symbols/NASDAQ-KMTS/etfs/", "source_name": "TradingView", "published_at": "2026-07-08T20:41:51", "published_display": "08 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "KMTS Q4'25 Earnings: revenue estimate is 26.48M USD", "summary": "Kestra Medical Technologies, Ltd. (KMTS) is scheduled to release its Q4'25 earnings on July 14, before market open. The company anticipates revenues of $26.48 million USD and an EPS of -$0.59 for the quarter. This article provides a detailed look at past revenue and EPS figures, ", "url": "https://www.tradingview.com/news/tradingview:b08e58af1c8a5:0-kmts-q4-25-earnings-revenue-estimate-is-26-48m-usd/", "source_name": "TradingView", "published_at": "2026-07-07T11:10:19", "published_display": "07 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "KMTS - Kestra Medical Technologies Ltd Options", "summary": "This article provides a detailed financial overview of Kestra Medical Technologies Ltd (KMTS), including its stock performance, market capitalization, income, sales, and various financial ratios. It also lists insider and institutional ownership, analyst recommendations, and othe", "url": "https://finviz.com/stock?t=KMTS&ta=1&p=d&ty=oc&b=1&r=m6", "source_name": "Finviz", "published_at": "2026-07-03T16:10:14", "published_display": "03 Jul 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical (KMTS) CBO adds 227 ESPP shares, now holds 42,488", "summary": "Kestra Medical Technologies' Chief Business Officer, Timothy P. Moran, purchased 227 shares of common stock through the company's 2025 Employee Stock Purchase Plan (ESPP) on June 30, 2026, at a price of $21.55 per share. This transaction, which was exempt under Rule 16b-3, increa", "url": "https://www.stocktitan.net/sec-filings/KMTS/form-4-kestra-medical-technologies-ltd-insider-trading-activity-5ceeaeb7d708.html", "source_name": "Stock Titan", "published_at": "2026-07-02T21:09:38", "published_display": "02 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical (KMTS) director and officer acquires 942 ESPP shares", "summary": "Kestra Medical Technologies director and officer Traci S. Umberger acquired 942 shares of common stock through the company's Employee Stock Purchase Plan at $21.55 per share. This purchase, exempt under Rule 16b-3, brings Umberger's beneficial ownership to 162,802 shares, includi", "url": "https://www.stocktitan.net/sec-filings/KMTS/form-4-kestra-medical-technologies-ltd-insider-trading-activity-81bd31ae21fc.html", "source_name": "Stock Titan", "published_at": "2026-07-02T21:09:38", "published_display": "02 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies to report Q4FY26 results on July 14", "summary": "Kestra Medical Technologies, a wearable medical device and digital healthcare company, will announce its Q4FY26 financial results after the market closes on July 14. This will be followed by a conference call at 4:30 p.m. ET to discuss the results and performance metrics for the ", "url": "https://scanx.trade/stock-market-news/companies/kestra-medical-technologies-to-report-q4fy26-results-on-july-14/44405856", "source_name": "scanx.trade", "published_at": "2026-07-01T04:27:00", "published_display": "01 Jul 2026 04:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies to Report Fourth Quarter Fiscal 2026 Financial Results on July 14", "summary": "Kestra Medical Technologies (Nasdaq: KMTS) announced it will report its fourth-quarter fiscal 2026 financial results after market close on Tuesday, July 14. The company will also host a conference call at 4:30 p.m. Eastern Time to discuss the results. A webcast of the call will b", "url": "https://finance.yahoo.com/healthcare/articles/kestra-medical-technologies-report-fourth-200500345.html", "source_name": "Market source", "published_at": "2026-07-01T02:39:48", "published_display": "01 Jul 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical sets July 14 earnings call after market close", "summary": "Kestra Medical Technologies (Nasdaq: KMTS) is scheduled to report its fourth-quarter fiscal 2026 financial results on Tuesday, July 14, after the market closes. Following the release, management will host a conference call at 4:30 p.m. Eastern Time to discuss the results, with a ", "url": "https://www.stocktitan.net/news/KMTS/kestra-medical-technologies-to-report-fourth-quarter-fiscal-2026-rntx9qpe8ahg.html", "source_name": "Stock Titan", "published_at": "2026-06-30T20:09:57", "published_display": "30 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies, Ltd.(NasdaqGS:KMTS) dropped from Russell 2000 Value Benchmark", "summary": "Kestra Medical Technologies, Ltd. (NasdaqGS:KMTS) has been dropped from the Russell 2000 Value Benchmark. This news follows several other announcements about the company being removed from various Russell indices around the same date in June 2026. The company is a commercial-stag", "url": "https://www.marketscreener.com/news/kestra-medical-technologies-ltd-nasdaqgs-kmts-dropped-from-russell-2000-value-benchmark-ce7f5fdcd888ff25", "source_name": "marketscreener.com", "published_at": "2026-06-30T07:10:05", "published_display": "30 Jun 2026 07:10", "sentiment": "negative", "sentiment_pct": 33, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies, Ltd.(NasdaqGS:KMTS) dropped from Russell 2500 Value Benchmark", "summary": "Kestra Medical Technologies, Ltd. (NasdaqGS: KMTS) has been removed from the Russell 2500 Value Benchmark. The company's stock shows a 3.34% increase today and a 5.13% year-to-date change. Kestra Medical Technologies specializes in wearable medical devices for cardiovascular dise", "url": "https://www.marketscreener.com/news/kestra-medical-technologies-ltd-nasdaqgs-kmts-dropped-from-russell-2500-value-benchmark-ce7f5fded880ff23", "source_name": "marketscreener.com", "published_at": "2026-06-30T04:40:32", "published_display": "30 Jun 2026 04:40", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies, Ltd.(NasdaqGS:KMTS) dropped from Russell 3000 Value Benchmark", "summary": "Kestra Medical Technologies, Ltd. (NasdaqGS:KMTS) has been removed from the Russell 3000 Value Benchmark. This news follows several other recent announcements where the company was dropped from various Russell indices, including the Russell Small Cap Comp Value and Russell 2500 V", "url": "https://www.marketscreener.com/news/kestra-medical-technologies-ltd-nasdaqgs-kmts-dropped-from-russell-3000-value-benchmark-ce7f5fdeda8ff622", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T14:39:15", "published_display": "29 Jun 2026 14:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies, Ltd.(NasdaqGS:KMTS) dropped from Russell Small Cap Comp Value Benchmark", "summary": "Kestra Medical Technologies, Ltd. (NasdaqGS:KMTS) has been removed from the Russell Small Cap Comp Value Benchmark. The company's stock experienced a slight drop of 0.79% on the day this news was published. This follows previous removals from other Russell indices and comes amids", "url": "https://www.marketscreener.com/news/kestra-medical-technologies-ltd-nasdaqgs-kmts-dropped-from-russell-small-cap-comp-value-benchmark-ce7f5fdede8df224", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T10:42:37", "published_display": "29 Jun 2026 10:42", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Kestra Medical Technologies (KMTS) Fully Priced As Sales Expansion Fuels The Bull Case?", "summary": "Kestra Medical Technologies (KMTS) has seen significant stock movement recently, prompting a closer look at its valuation. While a bullish narrative suggests it is 11.9% undervalued with a fair value of $30.00 due to sales force expansion and revenue growth, the company's current", "url": "https://www.sahmcapital.com/news/content/is-kestra-medical-technologies-kmts-fully-priced-as-sales-expansion-fuels-the-bull-case-2026-06-27", "source_name": "Sahm", "published_at": "2026-06-28T02:09:57", "published_display": "28 Jun 2026 02:09", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "KESTRA MEDICAL TECHNOLOGIES ($KMTS) Releases Q3 2026 Earnings, Stock Rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNdi0wOTYyRGJTX25WM3FJSU9KR0xJVDctLXV0aDhHLTVNNnJNWWxrNjhmU2xMMWFkTVRNUkFNc29CS280Q3VFeEtEZjZ4ZlYwZ2pCTzhVNGpQUEF3OXVUc1BaaWZwWW4xb1dLd3Q3SjBrZXBWN21FR2hKQm5OR3hHTElpZFFQM0l6UDdTMW00bDBLZkpOOHVfeDQxNVVzOFlfcV9aSnFQWktoNkU?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-27T06:26:29+00:00", "published_display": "27 Jun 2026 06:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies Ltd. Actuals & Estimates (NASDAQ:KMTS)", "summary": "This article provides financial actuals and estimates for Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), including its current stock price, market capitalization, and analyst forecasts. It details the company's past performance, upcoming earnings report, and financial metrics l", "url": "https://www.tradingview.com/symbols/NASDAQ-KMTS/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T01:09:11", "published_display": "27 Jun 2026 01:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "KMTS Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "The article provides a price target and forecast for Kestra Medical Technologies, Ltd. (KMTS) stock, based on analyst opinions. It includes current stock performance metrics, historical price data, financial statements, and answers frequently asked questions about the company's s", "url": "https://www.tradingview.com/symbols/NASDAQ-KMTS/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T14:09:40", "published_display": "25 Jun 2026 14:09", "sentiment": "positive", "sentiment_pct": 65, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQODBOU3plc3JYZ2VxcEZ6UFo5VzV1V3lQZ2dqZjVlWTlIZjRlUFlKLV8zYU0tQUlxcUtqNkRGS3dYTlBIWEw5ZWY2d05iRDBmbG80d3dQb1BseXRZUHBPTlZuOTFVQkhETGI0Vmk5OWpkcF9rYkdvbmxVM3pEcjhwU3BtMzFqX3YtQm9tVl9BSjhmMk80eU14S090M1AtR0hGSHc?oc=5", "source_name": "The Motley Fool", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies to Present at the BofA Securities 2026 Healthcare Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/kestra-medical-technologies-present-bofa-100000458.html", "source_name": "GlobeNewswire", "published_at": "2026-04-29T10:00:00+00:00", "published_display": "29 Apr 2026 10:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Showcases Accelerated Innovation at HRS 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/kestra-showcases-accelerated-innovation-hrs-120000033.html", "source_name": "GlobeNewswire", "published_at": "2026-04-22T12:00:00+00:00", "published_display": "22 Apr 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNd284TGpzWVFzSThkSlNjUE8zZjVWTGE0UnVGYW9kWk91ckhyMkhoUFZzMzBZWThjZWJ6SlJCM284bWRvUWtuZUZkX0dLTnlDRjVNWU5ONWtfdE1pR3Q5NzNDNFRTcGVhcVNVS2lzMG5KRXVGOXVLYXIzSWNwbXo0RUxTUnpwVlFTV0lrall3Z2Nzd2tiMlNRSFJMMG5yWG9kUS1kXzFZZ0lieDg?oc=5", "source_name": "Market source", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Kestra Medical Technologies (KMTS) Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNT0EyamNEZ1gwQjdKQmdEa2txVFRObVVPZWMzWU9sY3hEWm1rMGt5WjhSLW05aUVuaC1tSV9YX2NPaFVLTWZ6VVpEUmd4cGRBNnIybnlKckJQUVgyVmJ0Q1dVZVJydXl4OUJZdl9GRFpTSmVwYmp2dUxxUVhwaDVDaWpxRDFCOE9TenZValFYODNPY3FjSkpGUF9jdVkwdEhIb3RzNVB6aExBMzQ?oc=5", "source_name": "Market source", "published_at": "2026-03-28T07:00:00+00:00", "published_display": "28 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kestra Medical Technologies (KMTS) Revenue Growth Versus Ongoing EPS Losses Tests Bullish Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn\u2019t the Only Problem.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMTdzUkZQWG9tTW9zT3FxSWtzdkdLLUNYVkRJMDh2X1VRSlVrdmVkS3FCSVFpX210VUxVSUF1Q2FYakw1ZUxyQlpoZHZpM1RYQzBOYlpEWENxeGM1bXBZNFYxQjZRcFBpcS0tVVhRdzFTejBrVzU3aU9QQXdnYkZBMWxB?oc=5", "source_name": "Barron's", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Kestra Medical Technologies (NASDAQ:KMTS) A Risky Investment?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-09T07:00:00+00:00", "published_display": "09 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "KESTRA MED TECHNOLOGIES (KMTS) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFAyM0pSX3FHZzMzSGJuRmRvM3RyUWhpazQtSS01LUIzbjZLbWFzX1h3MEY4Ymk3d3k5U1IzUkZyeEtzNUVfblpXSG1MaUtZcHB1VXM0?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T17:15:22+00:00", "published_display": "24 Apr 2025 17:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 79, "total_relevant": 52, "sentiment_summary": {"positive": 11, "negative": 10, "neutral": 31, "score": 51, "total": 52, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 78, "events": [{"event": "earnings", "label": "Earnings", "weight": 15.0, "count": 26}, {"event": "general", "label": "Market update", "weight": 10.45, "count": 19}, {"event": "analyst", "label": "Analyst action", "weight": 2.75, "count": 5}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}], "positive_events": 11, "negative_events": 10}, "market_context": {"has_market_context": true, "latest_close": 25.99, "latest_week": "2026-07-10", "one_week_move": -3.7, "four_week_move": 24.7, "twelve_week_move": 13.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.90282, "market_dynamics_buy_signal": false, "relative_strength": -0.595975, "fair_value_gap": 17.4, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 51.8946, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.7% over one week, +24.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 58, "badges": [], "opportunities": [], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 9}, {"label": "TradingView", "count": 7}, {"label": "Market source", "count": 5}, {"label": "MarketBeat", "count": 3}, {"label": "marketscreener.com", "count": 3}, {"label": "GlobeNewswire", "count": 3}, {"label": "The Motley Fool", "count": 2}, {"label": "Quiver Quantitative", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 52}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 26}, {"label": "Market update", "count": 19}, {"label": "Analyst action", "count": 5}, {"label": "Deals and strategy", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "52", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.7% over one week, +24.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Kestra Medical Technologies (KMTS) Could Be 31% Overvalued As Earnings And 2027 Guidance Land"}], "updated_at": "2026-07-16T22:50:50.648301+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}